Abstract

The ongoing pandemic caused by the Betacoronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) demonstrates the urgent need of coordinated and rapid research towards inhibitors of the COVID-19 lung disease. The covid19-nmr consortium seeks to support drug development by providing publicly accessible NMR data on the viral RNA elements and proteins. The SARS-CoV-2 genome encodes for approximately 30 proteins, among them are the 16 so-called non-structural proteins (Nsps) of the replication/transcription complex. The 217-kDa large Nsp3 spans one polypeptide chain, but comprises multiple independent, yet functionally related domains including the viral papain-like protease. The Nsp3e sub-moiety contains a putative nucleic acid-binding domain (NAB) with so far unknown function and consensus target sequences, which are conceived to be both viral and host RNAs and DNAs, as well as protein-protein interactions. Its NMR-suitable size renders it an attractive object to study, both for understanding the SARS-CoV-2 architecture and drugability besides the classical virus’ proteases. We here report the near-complete NMR backbone chemical shifts of the putative Nsp3e NAB that reveal the secondary structure and compactness of the domain, and provide a basis for NMR-based investigations towards understanding and interfering with RNA- and small-molecule-binding by Nsp3e.

Highlights

  • SARS-CoV-2, the cause of the early 2020 pandemic accompanied by the respiratory disease called COVID-19, is the latest representative of the coronaviridae family, which comprises the 2002 first generation SARS-CoV and the Middle East Respiratory Syndrome (MERS)-CoV

  • Besides the structural Spike protein, important for viral entry, it is a set of non-structural proteins that represent the canonical protein drug targets, among them the two proteases Nsp5 (Mpro) and Nsp3d (PLpro), the Nsp3b ADP-ribose-phosphatase macrodomain, and the Nsp7/8/12 RNA-dependent RNA polymerase complex

  • Nsp3e is unique to Betacoronaviruses and consists of a nucleic acid-binding domain (NAB) and the so-called group 2-specific marker (G2M) (Neuman et al 2008)

Read more

Summary

Introduction

SARS-CoV-2, the cause of the early 2020 pandemic accompanied by the respiratory disease called COVID-19, is the latest representative of the coronaviridae family, which comprises the 2002 first generation SARS-CoV and the Middle East Respiratory Syndrome (MERS)-CoV. Keywords SARS-CoV-2 · Non-structural protein · Nucleic acid-binding domain · Solution NMR-spectroscopy · Protein drugability · Covid19-NMR

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call